UBS Group Cuts Amrize (NYSE:AMRZ) Price Target to $42.00

Amrize (NYSE:AMRZ) had its price objective trimmed by UBS Group from $57.00 to $42.00 in a research note released on Tuesday, Marketbeat reports. The firm currently has a neutral rating on the stock.

Several other analysts have also recently commented on the stock. William Blair set a $40.00 price target on shares of Amrize in a research note on Wednesday, September 2nd. Royal Bank Of Canada lowered Amrize from a “sector perform” rating to an “underperform” rating and cut their price objective for the company from $60.00 to $48.00 in a research report on Monday, August 10th. Citigroup cut Amrize from a “buy” rating to a “cautious” rating in a report on Wednesday, September 9th. Zacks Research downgraded Amrize from a “hold” rating to a “strong sell” rating in a research report on Wednesday, August 19th. Finally, Sanford C. Bernstein restated an “outperform” rating and set a $60.00 price target on shares of Amrize in a report on Monday. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, eight have issued a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $53.12.

Amrize Trading Down 2.0%

Shares of AMRZ opened at $37.15 on Tuesday. The firm has a market cap of $20.55 billion, a P/E ratio of 17.12, a price-to-earnings-growth ratio of 1.18 and a beta of 0.04. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.10 and a quick ratio of 0.73. Amrize has a 1 year low of $36.87 and a 1 year high of $65.94. The company has a 50 day simple moving average of $45.01 and a two-hundred day simple moving average of $50.90.

Amrize (NYSE:AMRZ) last released its earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing the consensus estimate of $0.92 by ($0.04). The company had revenue of $3.49 billion during the quarter. Amrize had a return on equity of 10.22% and a net margin of 9.89%. On average, equities analysts expect that Amrize will post 2.61 earnings per share for the current fiscal year.

Amrize Announces Dividend

The business also recently declared a dividend, which was paid on Wednesday, August 26th. Investors of record on Tuesday, August 18th were given a $0.11 dividend. The ex-dividend date was Tuesday, August 18th. Amrize’s dividend payout ratio (DPR) is currently 20.28%.

Insider Buying and Selling at Amrize

In other news, insider Stephen Clark bought 5,260 shares of Amrize stock in a transaction dated Tuesday, August 11th. The shares were acquired at an average price of $47.31 per share, with a total value of $248,850.60. Following the completion of the purchase, the insider owned 10,637 shares in the company, valued at $503,236.47. The trade was a 97.82% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Jan Jenisch purchased 26,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 2nd. The shares were purchased at an average cost of $42.47 per share, with a total value of $1,104,220.00. Following the completion of the purchase, the chief executive officer owned 1,767,000 shares in the company, valued at $75,044,490. This trade represents a 1.49% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last three months, insiders have purchased 48,983 shares of company stock valued at $2,158,755. Insiders own 0.54% of the company’s stock.

Institutional Investors Weigh In On Amrize

Institutional investors and hedge funds have recently modified their holdings of the business. MCF Advisors LLC bought a new position in Amrize in the 4th quarter valued at $27,000. Basepoint Wealth LLC bought a new stake in shares of Amrize during the fourth quarter worth $33,000. Continuum Advisory LLC purchased a new stake in shares of Amrize during the second quarter valued at $62,000. NewEdge Advisors LLC boosted its stake in shares of Amrize by 1,419.7% during the second quarter. NewEdge Advisors LLC now owns 2,082 shares of the company’s stock valued at $111,000 after purchasing an additional 1,945 shares during the period. Finally, Oslo Pensjonsforsikring AS bought a new position in shares of Amrize in the first quarter worth about $133,000.

Amrize Company Profile

Amrize is a North American building materials and solutions company formed through the separation of Holcim’s North American business. The company began trading publicly on the New York Stock Exchange in 2025 under the symbol AMRZ.

Amrize supplies essential construction materials, including cement, aggregates, ready-mix concrete and asphalt. It also provides a range of building products and solutions used in residential, commercial and infrastructure construction, including concrete products, roofing systems and other materials designed to support building and construction projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution operations and local businesses.